Tagal, V., Wei, S., Zhang, W., Brekken, R. A., Posner, B. A., Peyton, M., . . . Roth, M. G. (2017). SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers. Nature Portfolio.
Cita Chicago Style (17a ed.)Tagal, Vural, et al. SMARCA4-inactivating Mutations Increase Sensitivity to Aurora Kinase A Inhibitor VX-680 in Non-small Cell Lung Cancers. Nature Portfolio, 2017.
Cita MLA (8a ed.)Tagal, Vural, et al. SMARCA4-inactivating Mutations Increase Sensitivity to Aurora Kinase A Inhibitor VX-680 in Non-small Cell Lung Cancers. Nature Portfolio, 2017.
Precaución: Estas citas no son 100% exactas.